In tumor cells and HGSOC cells, overexpression of the anti-apoptotic protein Bcl-2 can inhibit apoptotic signals, thereby enhancing tumor cell resistance to chemotherapeutic agents (63). This evidence concerns the gene BCL2 and neoplasm.